Transferència
Patents
-
Evaluation of mantle cell lymphoma and methods related thereto
Inventors: Elías Campo, et al.
Priority number: US62325213
Priority date: 20/04/2016
PCT number: PCT/US2017/028628
PCT submission date: 20/04/2017
Patent publication code: WO2017184861
Patent publication date: 26/10/2017
Owner(s):HCB et al.
-
Method for determining lymphoma type
Inventors: Elías Campo, Andreas Rosenwald, Randy Gascoyne, Timothy Greiner, Dennis Weisenburger, Erlend B. Smeland, Jan Delabie, German Ott, Rita Braziel, Elaine S. Jaffe, Kai Fu, Wing Chan, Joo Song, James R. Cook
Priority number: US 62/519,728
Priority date: 14/06/2017
PCT number: PCT/US2018/036084
PCT submission date: 05/06/2018
Patent publication code: WO2018231589
Patent publication date: 20/12/2018
Owner(s): UB, IDIBAPS, HCB, et al.
-
Method to predict the clinical evolution of a patient suffering from chronic lymphocytic leukemia (CLL)
Inventors: José Ignacio Martín-Subero, Elías Campo, Carlos López
Priority number: EP12382391
Priority date: 11/10/2012
PCT number: PCT/EP2013/071065
PCT submission date: 09/10/2013
Patent publication code: WO2014056986
Patent publication date: 17/04/2014
Owner(s): UB, U. Oviedo, HCB
-
Methods for selecting and treating lymphoma types by means expression profiling
Inventors: Elías Campo, et al.
Priority number: US61/900,553
Priority date: 06/11/2013
PCT number: PCT/US2014/064161
PCT submission date: 05/11/2014
Patent publication code: WO2015069790
Patent publication date: 14/05/2015
Owner(s): HCB et al.
Guies clíniques
-
Newly diagnosed and relapsed mantle cell lymphoma: ESMO cPractice guidelines for diagnosis, treatment and follow-up
Authors: Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M; ESMO Guidelines Committee
Reference: Ann Oncol. 2017 Jul 1;28(suppl_4):iv62-iv71. doi: 10.1093/annonc/mdx223
-
WHO classification of tumors of haematopoietic and lymphoid tissues
Authors: Swerdlow SH, Campo E, Harris NL, Orazi A, Jaffe ES, Pileri S, Stein H, Thiele J, Hasserjian R, Vardiman JW (Eds)
Reference: IARC, Lyon 2017
-
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
Authors: Vitolo U, Seymour JF, Martelli M, Illerhaus G, Illidge T, Zucca E, Campo E, Ladetto M; ESMO Guidelines Committee
Reference: Ann Oncol. 2016 Sep;27(suppl 5):v91-v102
-
Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish cooperative group
Authors: Caballero D, Campo E, López-Guillermo A, Martín A, Arranz-Sáez R, Giné E, López A, González-Barca E, Canales MÁ, González-Díaz M, Orfao A
Reference: Ann Hematol. 2013 Sep;92(9):1151-79. doi: 10.1007/s00277-013-1783-4
-
ESMO consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma
Authors: Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E, Hermine O, Kluin-Nelemans JC, Ladetto M, Le Gouill S, Iannitto E, Pileri S, Rodríguez J, Schmitz N, Wotherspoon A, Zinzani P, Zucca E
Reference: Ann Oncol. 2013 Apr;24(4):857-77. doi: 10.1093/annonc/mds643
-
ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
Authors: Ghielmini M, Vitolo U, Kimby E, Montoto S, Walewski J, Pfreundschuh M, Federico M, Hoskin P, McNamara C, Caligaris-Cappio F, Stilgenbauer S, Marcus R, Trneny M, Dreger P, Montserrat E, Dreyling M; Panel Members of the 1st ESMO Consensus Conference on Malignant Lymphoma (Agostinelli C, Arcaini L, Caligaris-Cappio F, Campo E, Coiffier B, Corradini P, D'Amore F, Dreger P, Dreyling M, Federico M, Gallamini A, Gaulard P, Geisler CH, Ghielmini M, Gisselbrecht C, da Silva MG, Gribben J, Hermine O, Hoskin P, Iannitto E, Kim WS, Kimby E, Kluin-Nelemans HC, Koch P, Ladetto M, Le Gouill S, Lopez-Guillermo A, Marcus R, McNamara C, Montalban C, Montoto S, Montserrat E, Pfreundschuh M, Raderer M, Rodríguez J, Salles G, Bernard C, Schmitz N, Shpilberg O, Stilgenbauer S, Thieblemont C, Tilly H, Tournilhac O, Trümper L, Vitolo U, Walewski J, Wotherspoon A, Zucca E)
Reference: Ann Oncol. 2013 Mar;24(3):561-76. doi: 10.1093/annonc/mds517
-
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Authors: Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES
Reference: Blood. 2011 May 12;117(19):5019-32. doi: 10.1182/blood-2011-01-293050
-
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network
Authors: Klapper W, Hoster E, Determann O, Oschlies I, van der Laak J, Berger F, Bernd HW, Cabeçadas J, Campo E, Cogliatti S, Hansmann ML, Kluin PM, Kodet R, Krivolapov YA, Loddenkemper C, Stein H, Möller P, Barth TE, Müller-Hermelink K, Rosenwald A, Ott G, Pileri S, Ralfkiaer E, Rymkiewicz G, van Krieken JH, Wacker HH, Unterhalt M, Hiddemann W, Dreyling M; European MCL Network
Reference: J Hematop. 2009 Jul;2(2):103-11. doi: 10.1007/s12308-009-0036-x